Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Plos Pathogens|July 7, 2025
Proximity labelling of internalizing influenza A viruses reveals a role for neogenin in virus uptakeMilagros Sempere Borau, Victor G Gisbert, Josephine von Kempis, et al.Journal of Virology|May 12, 2007
Induction of MxA gene expression by influenza A virus requires type I or type III interferon signalingDirk Holzinger, Carl Jorns, Silke Stertz, et al.Journal of Virology|April 10, 2025
Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptorsOluwafemi F Adu, Milagros Sempere Borau, Simon P Früh, et al.Nature Communications|August 1, 2019
Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptationPatricia Domingues, Davide Eletto, Carsten Magnus, et al.Plos Pathogens|February 4, 2010
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccinesBalaji Manicassamy, Rafael A Medina, Rong Hai, et al.Scientific Reports|August 19, 2017
Identification of Polo-like kinases as potential novel drug targets for influenza A virusMarie O Pohl, Jessica von Recum-Knepper, Ariel Rodriguez-Frandsen, et al.Nature Communications|September 13, 2018
Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug targetEmilio Yángüez, Annika Hunziker, Maria Pamela Dobay, et al.Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.Nature Communications|October 27, 2010
Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virusRafael A Medina, Balaji Manicassamy, Silke Stertz, et al.The Journal of General Virology|July 28, 2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivirMarie O Pohl, Idoia Busnadiego, Francesco Marrafino, et al.Pageof 7